New hope for millions of osteoarthritis sufferers

Drug-free gel clinically proven to safely reduce joint pain caused by osteoarthritis

Developed by nano-physical medical device specialists Pro Bono Bio, FLEXISEQ is a drug-free topically applied gel, clinically proven to safely relieve pain and restore joint function among osteoarthritis (OA) sufferers.

Launched in the UK in January 2014, FLEXISEQ contains no active pharmaceutical ingredients, so users avoid the well-documented serious risks associated with common arthritic pain medications.

FLEXISEQ is absorbed through the skin, replenishing the depleted layer of lubricants otherwise found on healthy cartilage. The gel’s specially engineered droplets, called ‘Sequessome™ vesicles’, leave a lubricating layer around the affected joint, resulting in proven pain relief, increased mobility and a reduction in joint stiffness.

Research from several clinical studies proved that FLEXISEQ effectively improves joint mobility and eases pain for those suffering from OA and is proven to be as effective as a prescription painkiller1.

FLEXISEQ is increasingly used by professional athletes to manage their pain and improve joint flexibility, including Saracens, England and British & Irish Lions rugby player, Brad Barritt and Northampton Saints and England international Alex Corbisiero, as well as a number of professional rugby clubs including Leicester Tigers and Saracens.

Michael Earl, Chief Operating Officer of Pro Bono Bio said, “We’re delighted with how the UK has responded to FLEXISEQ since the launch of the product. The proven physical mode of action and the lack of an active pharmaceutical ingredient gives FLEXISEQ the best of both worlds: it works and it’s safe.”

FLEXISEQ is available for £18.49 in all good pharmacies across the UK, including LloydsPharmacy and Boots, as well as being available to purchase online.

For more information visit


FLEXISEQ is a topically applied drug-free gel which is clinically proven to safely relieve the pain and improve the joint stiffness associated with osteoarthritis (OA). There is extensive clinical data available from several randomised, double-blind clinical trials and FLEXISEQ is approved as a medical device for the treatment of all joints affected by OA.

FLEXISEQ is unique – it lubricates your joints to address joint damage. Pain is relieved and joint function improved because it lubricates away the friction and associated wear and tear on a user’s joints.

About Pro Bono Bio

Pro Bono Bio plc is the world’s leading nanotechnology company offering health and lifestyle products, headquartered in London with operations in Europe, Africa and Asia and due to launch in CIS and North America.